Cargando…
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
PURPOSE: Severe community-acquired pneumonia (sCAP) is associated with high morbidity and mortality, and whilst European and non-European guidelines are available for community-acquired pneumonia, there are no specific guidelines for sCAP. METHODS: The European Respiratory Society (ERS), European So...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069946/ https://www.ncbi.nlm.nih.gov/pubmed/37012484 http://dx.doi.org/10.1007/s00134-023-07033-8 |
_version_ | 1785018945145667584 |
---|---|
author | Martin-Loeches, Ignacio Torres, Antoni Nagavci, Blin Aliberti, Stefano Antonelli, Massimo Bassetti, Matteo Bos, Lieuwe D. Chalmers, James D. Derde, Lennie de Waele, Jan Garnacho-Montero, Jose Kollef, Marin Luna, Carlos M. Menendez, Rosario Niederman, Michael S. Ponomarev, Dmitry Restrepo, Marcos I. Rigau, David Schultz, Marcus J. Weiss, Emmanuel Welte, Tobias Wunderink, Richard |
author_facet | Martin-Loeches, Ignacio Torres, Antoni Nagavci, Blin Aliberti, Stefano Antonelli, Massimo Bassetti, Matteo Bos, Lieuwe D. Chalmers, James D. Derde, Lennie de Waele, Jan Garnacho-Montero, Jose Kollef, Marin Luna, Carlos M. Menendez, Rosario Niederman, Michael S. Ponomarev, Dmitry Restrepo, Marcos I. Rigau, David Schultz, Marcus J. Weiss, Emmanuel Welte, Tobias Wunderink, Richard |
author_sort | Martin-Loeches, Ignacio |
collection | PubMed |
description | PURPOSE: Severe community-acquired pneumonia (sCAP) is associated with high morbidity and mortality, and whilst European and non-European guidelines are available for community-acquired pneumonia, there are no specific guidelines for sCAP. METHODS: The European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and Latin American Thoracic Association (ALAT) launched a task force to develop the first international guidelines for sCAP. The panel comprised a total of 18 European and four non-European experts, as well as two methodologists. Eight clinical questions for sCAP diagnosis and treatment were chosen to be addressed. Systematic literature searches were performed in several databases. Meta-analyses were performed for evidence synthesis, whenever possible. The quality of evidence was assessed with GRADE (Grading of Recommendations, Assessment, Development and Evaluation). Evidence to Decision frameworks were used to decide on the direction and strength of recommendations. RESULTS: Recommendations issued were related to diagnosis, antibiotics, organ support, biomarkers and co-adjuvant therapy. After considering the confidence in effect estimates, the importance of outcomes studied, desirable and undesirable consequences of treatment, cost, feasibility, acceptability of the intervention and implications to health equity, recommendations were made for or against specific treatment interventions. CONCLUSIONS: In these international guidelines, ERS, ESICM, ESCMID, and ALAT provide evidence-based clinical practice recommendations for diagnosis, empirical treatment, and antibiotic therapy for sCAP, following the GRADE approach. Furthermore, current knowledge gaps have been highlighted and recommendations for future research have been made. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00134-023-07033-8. |
format | Online Article Text |
id | pubmed-10069946 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-100699462023-04-04 ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia Martin-Loeches, Ignacio Torres, Antoni Nagavci, Blin Aliberti, Stefano Antonelli, Massimo Bassetti, Matteo Bos, Lieuwe D. Chalmers, James D. Derde, Lennie de Waele, Jan Garnacho-Montero, Jose Kollef, Marin Luna, Carlos M. Menendez, Rosario Niederman, Michael S. Ponomarev, Dmitry Restrepo, Marcos I. Rigau, David Schultz, Marcus J. Weiss, Emmanuel Welte, Tobias Wunderink, Richard Intensive Care Med Guidelines PURPOSE: Severe community-acquired pneumonia (sCAP) is associated with high morbidity and mortality, and whilst European and non-European guidelines are available for community-acquired pneumonia, there are no specific guidelines for sCAP. METHODS: The European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and Latin American Thoracic Association (ALAT) launched a task force to develop the first international guidelines for sCAP. The panel comprised a total of 18 European and four non-European experts, as well as two methodologists. Eight clinical questions for sCAP diagnosis and treatment were chosen to be addressed. Systematic literature searches were performed in several databases. Meta-analyses were performed for evidence synthesis, whenever possible. The quality of evidence was assessed with GRADE (Grading of Recommendations, Assessment, Development and Evaluation). Evidence to Decision frameworks were used to decide on the direction and strength of recommendations. RESULTS: Recommendations issued were related to diagnosis, antibiotics, organ support, biomarkers and co-adjuvant therapy. After considering the confidence in effect estimates, the importance of outcomes studied, desirable and undesirable consequences of treatment, cost, feasibility, acceptability of the intervention and implications to health equity, recommendations were made for or against specific treatment interventions. CONCLUSIONS: In these international guidelines, ERS, ESICM, ESCMID, and ALAT provide evidence-based clinical practice recommendations for diagnosis, empirical treatment, and antibiotic therapy for sCAP, following the GRADE approach. Furthermore, current knowledge gaps have been highlighted and recommendations for future research have been made. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00134-023-07033-8. Springer Berlin Heidelberg 2023-04-04 /pmc/articles/PMC10069946/ /pubmed/37012484 http://dx.doi.org/10.1007/s00134-023-07033-8 Text en © This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2023, corrected publication 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Guidelines Martin-Loeches, Ignacio Torres, Antoni Nagavci, Blin Aliberti, Stefano Antonelli, Massimo Bassetti, Matteo Bos, Lieuwe D. Chalmers, James D. Derde, Lennie de Waele, Jan Garnacho-Montero, Jose Kollef, Marin Luna, Carlos M. Menendez, Rosario Niederman, Michael S. Ponomarev, Dmitry Restrepo, Marcos I. Rigau, David Schultz, Marcus J. Weiss, Emmanuel Welte, Tobias Wunderink, Richard ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia |
title | ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia |
title_full | ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia |
title_fullStr | ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia |
title_full_unstemmed | ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia |
title_short | ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia |
title_sort | ers/esicm/escmid/alat guidelines for the management of severe community-acquired pneumonia |
topic | Guidelines |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069946/ https://www.ncbi.nlm.nih.gov/pubmed/37012484 http://dx.doi.org/10.1007/s00134-023-07033-8 |
work_keys_str_mv | AT martinloechesignacio ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT torresantoni ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT nagavciblin ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT alibertistefano ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT antonellimassimo ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT bassettimatteo ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT boslieuwed ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT chalmersjamesd ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT derdelennie ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT dewaelejan ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT garnachomonterojose ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT kollefmarin ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT lunacarlosm ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT menendezrosario ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT niedermanmichaels ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT ponomarevdmitry ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT restrepomarcosi ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT rigaudavid ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT schultzmarcusj ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT weissemmanuel ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT weltetobias ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia AT wunderinkrichard ersesicmescmidalatguidelinesforthemanagementofseverecommunityacquiredpneumonia |